AUXILIUM PHARMACEUTICALS INC Research and Development Expense
AUXILIUM PHARMACEUTICALS INC reported Research and Development Expense of $11.22 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-10-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-10-30
- AUXILIUM PHARMACEUTICALS INC research and development expense for the quarter ending 2014-09-30 was $11.22M, a 5.03% decline year-over-year.
- AUXILIUM PHARMACEUTICALS INC research and development expense for the quarter ending 2014-06-30 was $11.30M, a 17.05% decline year-over-year.
- AUXILIUM PHARMACEUTICALS INC research and development expense for the quarter ending 2014-03-31 was $10.99M, a 7.29% decline year-over-year.
- AUXILIUM PHARMACEUTICALS INC research and development expense for the quarter ending 2013-12-31 was $12.91M, a 1.90% decline year-over-year.
- AUXILIUM PHARMACEUTICALS INC research and development expense for fiscal 2013 was $50.21M, a 9.32% increase from fiscal 2012.
- AUXILIUM PHARMACEUTICALS INC research and development expense for fiscal 2012 was $45.93M, a 25.85% decline from fiscal 2011.
- AUXILIUM PHARMACEUTICALS INC research and development expense for fiscal 2011 was $61.95M, a 29.04% increase from fiscal 2010.
- AUXILIUM PHARMACEUTICALS INC research and development expense for fiscal 2010 was $48.01M, a 6.60% decline from fiscal 2009.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2014-09-30 | $11.22M 10-Q · filed 2014-10-30 | $22.52M derived: sum of 2 quarters · filed 2014-10-30 | $33.52M 10-Q · filed 2014-10-30 | $46.43M derived: sum of 4 quarters · filed 2014-10-30 | |
| 2014-06-30 | $11.30M 10-Q · filed 2014-08-07 | $22.30M 10-Q · filed 2014-08-07 | $35.21M derived: sum of 3 quarters · filed 2014-08-07 | $47.02M derived: sum of 4 quarters · filed 2014-10-30 | |
| 2014-03-31 | $10.99M 10-Q · filed 2014-05-05 | $23.91M derived: sum of 2 quarters · filed 2014-05-05 | $35.72M derived: sum of 3 quarters · filed 2014-10-30 | $49.35M derived: sum of 4 quarters · filed 2014-10-30 | |
| 2013-12-31 | $12.91M 10-K · filed 2014-02-28 | $24.73M derived: sum of 2 quarters · filed 2014-10-30 | $38.35M derived: sum of 3 quarters · filed 2014-10-30 | $50.21M 10-K · filed 2014-02-28 | |
| 2013-09-30 | $11.82M 10-Q · filed 2014-10-30 | $25.44M derived: sum of 2 quarters · filed 2014-10-30 | $37.30M 10-Q · filed 2014-10-30 | $50.46M derived: sum of 4 quarters · filed 2014-10-30 | |
| 2013-06-30 | $13.63M 10-Q · filed 2014-08-07 | $25.48M 10-Q · filed 2014-08-07 | $38.65M derived: sum of 3 quarters · filed 2014-08-07 | $49.24M derived: sum of 4 quarters · filed 2014-08-07 | |
| 2013-03-31 | $11.86M 10-Q · filed 2014-05-05 | $25.02M derived: sum of 2 quarters · filed 2014-05-05 | $35.61M derived: sum of 3 quarters · filed 2014-05-05 | $45.80M derived: sum of 4 quarters · filed 2014-05-05 | |
| 2012-12-31 | $13.16M 10-K · filed 2014-02-28 | $23.75M derived: sum of 2 quarters · filed 2014-02-28 | $33.94M derived: sum of 3 quarters · filed 2014-02-28 | $45.93M 10-K · filed 2014-02-28 | |
| 2012-09-30 | $10.59M 10-K · filed 2014-02-28 | $20.78M derived: sum of 2 quarters · filed 2014-02-28 | $32.77M 10-Q · filed 2013-11-06 | $51.49M derived: sum of 4 quarters · filed 2014-02-28 | |
| 2012-06-30 | $10.19M 10-K · filed 2014-02-28 | $22.18M 10-Q · filed 2013-08-01 | $40.90M derived: sum of 3 quarters · filed 2014-02-28 | $55.06M derived: sum of 4 quarters · filed 2014-02-28 | |
| 2012-03-31 | $11.99M 10-K · filed 2014-02-28 | $30.71M derived: sum of 2 quarters · filed 2014-02-28 | $44.87M derived: sum of 3 quarters · filed 2014-02-28 | $58.19M derived: sum of 4 quarters · filed 2014-02-28 | |
| 2011-12-31 | $18.72M 10-K · filed 2013-02-26 | $32.88M derived: sum of 2 quarters · filed 2013-02-26 | $46.19M derived: sum of 3 quarters · filed 2013-02-26 | $61.95M 10-K · filed 2014-02-28 | |
| 2011-09-30 | $14.16M 10-K · filed 2013-02-26 | $27.48M derived: sum of 2 quarters · filed 2013-02-26 | $43.23M 10-Q · filed 2012-11-08 | $57.18M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-06-30 | $13.31M 10-K · filed 2013-02-26 | $29.07M 10-Q · filed 2012-07-31 | $43.02M derived: sum of 3 quarters · filed 2013-02-26 | $57.45M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-03-31 | $15.75M 10-K · filed 2013-02-26 | $29.71M derived: sum of 2 quarters · filed 2013-02-26 | $44.14M derived: sum of 3 quarters · filed 2013-02-26 | $55.28M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2010-12-31 | $13.95M 10-K · filed 2012-02-29 | $28.38M derived: sum of 2 quarters · filed 2012-02-29 | $39.52M derived: sum of 3 quarters · filed 2012-02-29 | $48.01M 10-K · filed 2013-02-26 | |
| 2010-09-30 | $14.43M 10-K · filed 2012-02-29 | $25.57M derived: sum of 2 quarters · filed 2012-02-29 | $34.05M 10-Q · filed 2011-11-09 | $45.53M derived: sum of 4 quarters · filed 2012-02-29 | |
| 2010-06-30 | $11.14M 10-K · filed 2012-02-29 | $19.62M 10-Q · filed 2011-08-02 | $31.10M derived: sum of 3 quarters · filed 2012-02-29 | $43.85M derived: sum of 4 quarters · filed 2012-02-29 | |
| 2010-03-31 | $8.58M 10-K · filed 2012-02-29 | $8.48M 10-Q · filed 2011-05-10 | $19.95M derived: sum of 2 quarters · filed 2012-02-29 | $32.71M derived: sum of 3 quarters · filed 2012-02-29 | $46.44M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | $11.38M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $24.13M derived: sum of 2 quarters · filed 2012-02-29 | $37.86M derived: sum of 3 quarters · filed 2012-02-29 | $51.40M 10-K · filed 2012-02-29 | |
| 2009-09-30 | $12.75M 10-Q · filed 2010-11-08 | $26.49M derived: sum of 2 quarters · filed 2010-11-08 | $40.02M 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | $13.73M 10-Q · filed 2010-08-06 | $27.27M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | $54.50M 10-K · filed 2011-03-01 |